Infographic: The Feline Patient and Cannabinoids
Research by: MVZ Flor Ortiz
All cats possess an Endocannabinoid System (ECS). That’s why they can be candidates for treatment with CBD and other cannabinoids.
According to several studies, cannabinoids can help treat several problems such as asthma, glaucoma, gingivostomatitis, cancer, and dermatological ailments, among others.
The following infographic how cannabis-derived medications may be a good alternative to improve feline quality of life:
ICAN® Todos los derechos reservados. No se permite la modificación de las imágenes ni los textos aquí contenidos. Se permite su reproducción sin modificación cuando se cite a ICAN como autor y se enlace a www.ican.mx y/o al Facebook @ICANvets. Diseño: Zaira Orozco
The feline patient and cannabinoids by ICAN Vets is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at https://www.ican.mx/blog/infograph-cbd-for-cats.
References:
Buranakarn V. (2020). Sarcoma cancer treatment using extracted cannabis oil in a cat. Int J Innov Res Sci Eng Technol; 3:35–40.
Cital, S. y Hughston, L. (2021). Cannabinoids in cats: use and misuse. Feline focus, 7(5), 121-130.
Cital, S., Kramer, K., Hughston, L., y Gaynor, J. (Eds.). (2021). Cannabis Therapy in Veterinary Medicine: A Complete Guide. https://doi.org/10.1007/978-3-030-68317-7.
De Briyne, N., Holmes, D., Sandler, I., Stiles, E., Szymanski, D., Moody, S., Neumann, S., y Anadón, A. (2021). Cannabis, cannabidiol oils and tetrahydrocannabinol—what do veterinarians need to know? Animals, 11(3), 1–19. https://doi.org/10.3390/ani11030892
Hazzah, T., Andre, C., Richter, G., y Mcgrath, S. (2020). Cannabis in Veterinary Medicine: A Critical Review. AHVMA Journal, 61, 17–41.
López López, S.M., Yaafar González, N.E. (2020). CANNABIS MEDICINAL: OPCIÓN TERAPÉUTICA PARA EN EL ASMA FELINO. REMEVET. EDICIÓN ESPECIAL VETCANN I-2020, 15-19.
McCarthy. L. E. y Borinson H. L. (1981). Antiemetic Activity of N-Methyllevonantradol and Nahilone in Cisplatin-Treated cats. J Clin Pharmacol; 21:30S-37S.
Miragliotta, V., Ricci, P. L., Albanese, F., Pirone, A., Tognotti, D. y Abramo, F. (2018). Cannabinoid receptor types 1 and 2 and peroxisome proliferator-activated receptor-α: distribution in the skin of clinically healthy cats and cats with hypersensitivity dermatitis. Vet Dermatol. DOI: 10.1111/vde.12658
Polidoro, G., Galiazzo, G., Giancola, F., et al. (2020). Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis. J Feline Med Surg, 21, 1165–1171.
Scarampella, F., Abramo, F. y Noli, C. (2001). Clinical and histological evaluation of an analogue of Palmitoylethanolamide. PLR 20 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study. Veterinary Dermatology, 12 (1), 29-39. DOI:10.1046/j.1365-3164.2001.00214.x
Stanzani, A., Galiazzo, G., Giancola, F., et al. (2020). Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract. Histochem Cell Biol, 153, 339–356.
Zadik-Weiss, L., Ritter, S., Hermush, V., Asher, N., Avital, A., & Or, R. (2020). Feline cognitive dysfunction as a model for Alzheimer’s disease in the research of CBD as a potential treatment—a narrative review. Journal of Cannabis Research, 2(1), 0–5. https://doi.org/10.1186/s42238-020-00054-w
Aebersold, A., Duff, M., Sloan, L., & Song, Z. H. (2021). Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 55(S5), 1–14. https://doi.org/10.33594/000000371
